Home > Papers

 
 
Design,Preparation and in vitro Bioactivity of Monopegylated Recombinant Hirudin
Hou Beibei #,Li Shirong ,Li Xiaohui ,Xiu Zhilong
Dalian University of Technology
*Correspondence author
#Submitted by
Subject:
Funding: none
Opened online:28 November 2006
Accepted by: none
Citation: Hou Beibei ,Li Shirong ,Li Xiaohui .Design,Preparation and in vitro Bioactivity of Monopegylated Recombinant Hirudin[OL]. [28 November 2006] http://en.paper.edu.cn/en_releasepaper/content/9973
 
 
Hirudin is the most potent inhibitor of thrombin found in nature. As a promising anticoagulant, a significant drawback which significantly inhibits its clinical application, is the short serum half-life. In order to prolong circulation half-life in vivo, PEGylation is an effective and commonly used method. In this study Succinimidyl carbonyl mPEG (SC-mPEG) 20kDa was attached to recombinant hirudin (r-Hir) at mildly acidic pH to favor the formation of mono- PEGylated r-Hir, since histidine residues represent the preferred PEGylation sites under mildly acidic conditions, and there is only one histidine residue, His51, in r-Hir. Because of the high ratio of monopegylated product, the reaction mixture was easily separated by a one-step ion-exchange chromatographic(IEC) separation procedure. The proportion of urethane bonds involving carboxyalkylated histidines was assayed using its sensitivity to neutral hydroxylamine, and about 79.71% of the mono-substituted PEGylated r-Hir was PEGylated
Keywords:r-Hir; histidine residues; SC-mPEG; monopegylation; pH; anticoagulant activity
 
 
 

For this paper

  • PDF (0B)
  • ● Revision 0   
  • ● Print this paper
  • ● Recommend this paper to a friend
  • ● Add to my favorite list

    Saved Papers

    Please enter a name for this paper to be shown in your personalized Saved Papers list

Tags

Add yours

Related Papers

Statistics

PDF Downloaded 939
Bookmarked 0
Recommend 5
Comments Array
Submit your papers